Sustainability & Climate

Promising new 96-week data shows Vir's therapy could redefine care for severe hepatitis delta, as its oncology pipeline and financial runway also advance.

Erasca reports promising early data for its pan-RAS inhibitor, ERAS-0015, showing tumor shrinkage at low doses and shaking up the competitive landscape.

With preliminary Q1 revenue of $103.7M, Twist Bioscience beats forecasts, setting a bullish tone ahead of its full earnings report on February 2nd.

The genomics leader posted a 41% revenue surge in 2025 and projects profitability, yet its stock tumbled on what some see as conservative 2026 guidance.

With a major strategic pivot complete, Gibraltar Industries' leadership will outline its 2026 playbook to investors at a key 'New Ideas' conference.

With its new thalassemia drug AQVESME launching, Agios aims for blockbuster status while navigating a key safety warning and advancing a broad pipeline.

As a foundational CFO steps down, XOMA Royalty brings in biotech veteran Jeffrey Trigilio to enhance its dealmaking strategy and expand its royalty portfolio.

With pivotal cancer drug data looming and a new nuclear supply chain, Bicycle Therapeutics is betting big on its novel platform. Will 2026 be its breakout year?

IVECO and PlusAI are deploying Level 4 autonomous trucks on a key Spanish freight corridor, heralding a new era for logistics in Southern Europe.

Cytek Biosciences reports preliminary 2025 revenue of $201M, beating estimates with a major Q4 growth surge ahead of its key J.P. Morgan presentation.

CoinEx's consistent token burning removes over 166M CET in a year, signaling a long-term commitment to scarcity and value in a competitive market.

National fencer Saif Nordin partners with Dr.stretch, bringing elite athletic recovery to the public to combat a national mobility issue costing millions.

Dolf van den Brink will step down in 2026 after a turbulent tenure, leaving an ambitious new strategy for his successor to execute amid market skepticism.

A federal plan for the Colorado River's future ignites fears of 'dramatic cuts' for 20 million Californians and threatens a multi-state legal war.

Recent findings of bacteria and heavy metals in baby formula have parents worried and legal experts demanding greater manufacturer accountability.

With booming revenue, a potential blockbuster on the horizon, and key partnerships, Ascendis Pharma lays out a bold roadmap for global dominance.

The University of Tulsa celebrates a historic achievement as 11 students secure prestigious Gilman scholarships, unlocking transformative study abroad experiences.

The family of a motorcyclist killed by a Tesla on Autopilot files a wrongful death suit, citing a history of deceptive marketing and known system flaws.

MES Life Safety has offloaded its alleged PFAS liabilities to a third party, a strategic move to de-risk its finances and focus on its core mission.

Kourtney Kardashian Barker's wellness brand Lemme enters performance nutrition with a science-backed creatine gummy, aiming to mainstream the supplement for women.